These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo. Hussain I, Hawkins J, Harrison D, Hille C, Wayne G, Cutler L, Buck T, Walter D, Demont E, Howes C, Naylor A, Jeffrey P, Gonzalez MI, Dingwall C, Michel A, Redshaw S, Davis JB. J Neurochem; 2007 Feb 28; 100(3):802-9. PubMed ID: 17156133 [Abstract] [Full Text] [Related]
13. Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer's Disease Cell Model. Liang H, Shi Y, Kou Z, Peng Y, Chen W, Li X, Li S, Wang Y, Wang F, Zhang X. PLoS One; 2015 Feb 28; 10(10):e0140733. PubMed ID: 26473367 [Abstract] [Full Text] [Related]
17. Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells. Yoshida H, Meng P, Matsumiya T, Tanji K, Hayakari R, Xing F, Wang L, Tsuruga K, Tanaka H, Mimura J, Kosaka K, Itoh K, Takahashi I, Imaizumi T. Neurosci Res; 2014 Feb 28; 79():83-93. PubMed ID: 24295810 [Abstract] [Full Text] [Related]
18. beta-Secretase, APP and Abeta in Alzheimer's disease. Vassar R. Subcell Biochem; 2005 Feb 28; 38():79-103. PubMed ID: 15709474 [Abstract] [Full Text] [Related]
19. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E, Torrance M, Mante M, Adame A, Paulino A, Rose JB, Crews L, Moessler H, Masliah E. J Neurosci Res; 2006 May 15; 83(7):1252-61. PubMed ID: 16511867 [Abstract] [Full Text] [Related]